These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6499731

  • 1. [The effect of antitumor vaccine on the recurrence of solid tumors in mice subjected to surgery].
    Zatula DG, Bikhunov VL, Zagoruĭko EE.
    Eksp Onkol; 1984; 6(1):47-9. PubMed ID: 6499731
    [Abstract] [Full Text] [Related]

  • 2. Suppression of cell-mediated tumor cell lysis and complement-induced cytotoxicity by trypan blue.
    Scornik JC, Ruiz P, Hoffman EM.
    J Immunol; 1979 Sep; 123(3):1278-84. PubMed ID: 469250
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors.
    Hájková R, Indrová M, Jandlová T, Bubeník J, Reinis M.
    Folia Biol (Praha); 1999 Sep; 45(6):227-31. PubMed ID: 10732718
    [Abstract] [Full Text] [Related]

  • 4. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
    Kataoka T, Oh-hashi F, Sakurai Y, Gomi K.
    Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642
    [Abstract] [Full Text] [Related]

  • 5. Abrogation of tumor rejection by trypan blue.
    Kreider JW, Bartlett GL, DeFreitas E.
    Cancer Res; 1978 Apr; 38(4):1036-40. PubMed ID: 205342
    [Abstract] [Full Text] [Related]

  • 6. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y, Saxena A, Zheng C, Carlsen S, Xiang J.
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [Abstract] [Full Text] [Related]

  • 7. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL, Kearney R.
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [Abstract] [Full Text] [Related]

  • 8. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice.
    Sheeja K, Kuttan G.
    Integr Cancer Ther; 2007 Mar; 6(1):66-73. PubMed ID: 17351028
    [Abstract] [Full Text] [Related]

  • 9. A vaccine and immune serum for ascites tumor of mice and therapy of skin tumors.
    Ryu E.
    Dev Biol Stand; 2007 Mar; 38():381-5. PubMed ID: 608527
    [Abstract] [Full Text] [Related]

  • 10. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
    Mikysková R, Indrová M, Símová J, Jandlová T, Bieblová J, Jinoch P, Bubeník J, Vonka V.
    Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
    [Abstract] [Full Text] [Related]

  • 11. Specific passive immunotherapy of experimental lymphoma. Effects of macrophage toxic drugs.
    Gerlier D, Avice T, Doré JF.
    Biomedicine; 1979 Jul; 31(4):106-10. PubMed ID: 226195
    [Abstract] [Full Text] [Related]

  • 12. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
    Hall RE, Muchmore AV, Blaese RM.
    J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
    [Abstract] [Full Text] [Related]

  • 13. Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.
    Peng B, Liang L, Chen Z, He Q, Kuang M, Zhou F, Lu M, Huang J.
    Hepatogastroenterology; 2006 Sep; 53(69):409-14. PubMed ID: 16795983
    [Abstract] [Full Text] [Related]

  • 14. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
    Kozin SV, Kozina LV.
    Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
    [Abstract] [Full Text] [Related]

  • 15. Influence of 5-hydroxytryptamine on the combination effect of lonidamine or gossypol and hyperthermia on Ehrlich tumour in vivo.
    Molla MR, Yoshiga K, Takada K.
    Anticancer Res; 1987 Jan; 7(3 Pt B):361-4. PubMed ID: 3631888
    [Abstract] [Full Text] [Related]

  • 16. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
    Jakóbisiak M, Kańtoch M, Lasek W, Rozmysłowicz T, Obłakowski P, Dobaczewska H.
    Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
    [No Abstract] [Full Text] [Related]

  • 17. The role of alpha-difluoromethyl ornithine as an adjuvant to immunotherapy in mice bearing transplantable tumors.
    Chowdhury SR, Guha S, Sen U.
    Neoplasma; 1994 Jan; 41(3):159-61. PubMed ID: 7935984
    [Abstract] [Full Text] [Related]

  • 18. Effect of trypan blue on the activity of lysosomal enzymes, tumor growth and cell ultrastructure in B16 melanotic melanoma in mice.
    Kozlowska H, Drewa G, Grzanka A.
    Neoplasma; 1995 Jan; 42(4):173-8. PubMed ID: 7659182
    [Abstract] [Full Text] [Related]

  • 19. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M, Bubeník J, Mikysková R, Mendoza L, Símová J, Bieblová J, Jandlová T, Jinoch P, Smahel M, Vonka V, Pajtasz-Piasecka E.
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [Abstract] [Full Text] [Related]

  • 20. [The role of serum humoral factors in metastasis and recurrence of Ehrlich carcinoma in mice].
    Donenko FV, Sitdikova SM, Moroz LV.
    Biull Eksp Biol Med; 1997 Oct; 124(10):443-5. PubMed ID: 9410180
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.